Logo

PharmaMar Has Announced That the Spanish Medicines Agency Has ...

MADRID, April 28, 2020 /PRNewswire-AsiaNet/ -- - The objective of the trial is to evaluate the efficacy and safety of plitidepsin in patients with COVID-19 requiring hospital admission- Plitidepsin recently obtained positive results from in vitro studies on the human HCoV-229E coronavirus,...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660